Vyro Bio
Vyro develops oncolytic viruses designed to target CNS tumors, based on pioneering research on the oncolytic properties of the Zika Virus.
Business Model:
Revenue: $0
Employees: 1-10
Rankings
Industries / Tags:
Detailed Vyro Bio Information
Geographic Data
Address:
City: São Paulo
State: Sao Paulo
Zip:
Country: Brazil
Financial Info
Stage:
seed
Raised Last:
$2M
Raised Total:$2M
Social
Metrics
6,048,835Website Global Rank
1,267Website Monthly Traffic
Twitter Followers
Description
Vyro is an immuno-oncology (I-O) biotechnology company developing cancer-killing, or ‘oncolytic’, viruses (OVs) designed to target adult and pediatric central nervous system (CNS) tumors, based on pioneering research and breakthrough discovery of the oncolytic properties of the Zika Virus (ZIKV).
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 2/2022 | Seed Round | 1 | $1.5M |
Vesper Ventures SA Vesper Ventures SA |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
